仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Lucatumumab （HCD122） is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity （ADCC） and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research